CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 11,990
-340 (-2.76%)
Nov 2, 2026, 3:30 PM KST
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 65.78 billion as of November 2, 2026. It is the 30,111th most valuable company in the world and the 1,564th biggest in South Korea. Its market cap has decreased by 44.49% in one year.
Market Cap
65.78B
Enterprise Value
n/a
Revenue
159.93B
Global Rank
Country Rank
#1,564 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 65.78B, an increase of 548.29%. That is a compound annual growth rate of 7.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 65.78B | -41.08% |
| Dec 30, 2025 | 111.64B | -7.50% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 122.88B |
| SAMSUNG PHARM. Co., LTD. | 113.23B |
| Dong Sung Bio Pharm.Co.,Ltd. | 112.29B |
| HANDOK | 106.66B |
| Jeil Pharma Holdings | 103.16B |
| Enzychem Lifesciences | 76.86B |
| Kukje Pharma | 70.78B |
| Ildong Holdings | 65.32B |